Pharmacokinetics of diazepam in the dog.
After i.v. administration of 2 mg/kg diazepam to dogs, concentrations of unmetabolized drug showed a triexponential decline with an average elimination half-life t0.5(beta) of 3.2 hr. Desmethyldiazepam appeared rapidly in plasma and exceeded diazepam concentrations by far. Elimination half-lives of this metabolite averaged 3.6 hr. Oxazepam reached maximal plasma concentrations in the range of 100 ng/ml after about 2 hr which then declined with a half-life of 5.7 hr. When the sum of the concentrations of diazepam and its active metabolites was plotted against time, the curve could be fitted by an open 2-compartment model, so that one of the apparent 3 compartments in the distribution of diazepam must be assumed to represent first pass demethylation to desmethyldiazepam. After oral administration of the same dose, desmethyldiazepam concentrations exceeded those of diazepam from the first blood sample taken. The share of unmetabolized diazepam in the total area under curve was only 1-3% after oral administration, but 7-21% after i.v. administration. Oral bioavailability was in the range of 74-100%. By continued oral administration of 1 or 2 mg/kg diazepam t.i.d. it was possible to maintain steady state plasma concentrations of 1000-2000 ng/ml desmethyldiazepam and maximal diazepam concentrations of 100-800 ng/ml. Oxazepam did not exceed a concentration of 100-200 ng/ml and small concentrations of 3-hydroxydiazepam could also be detected in these experiments. There was no indication of enzyme induction by this dose regimen. Both diazepam and desmethyldiazepam rapidly passed the blood/CSF barrier and reached steady state concentrations is CSF corresponding to the part not bound to serum proteins.
D000284:Administration, Oral; D000818:Animals; D001682:Biological Availability; D001711:Biotransformation; D001798:Blood Proteins / Q000378:metabolism; D002849:Chromatography, Gas; D003975:Diazepam / Q000008:administration & dosage / Q000378:metabolism*; D004285:Dogs; D005260:Female; D006207:Half-Life; D007275:Injections, Intravenous; D007700:Kinetics; D008297:Male; D011485:Protein Binding
D001798:Blood Proteins; D003975:Diazepam